-
公开(公告)号:ZA9603237B
公开(公告)日:1996-07-29
申请号:ZA9603237
申请日:1996-04-23
Applicant: ABBOTT LAB
Inventor: SHEN WANG , ROSENBERG SAUL H , ARENDSEN DAVID L , O'CONNOR STEPHEN J , FAKHOURY STEPHEN A , GARVEY DAVID S , FUNG ANTHONY K L , STEIN HERMAN H
IPC: A61K20060101 , C07C20060101 , C07D20060101 , A61K , C07C , C07D
-
22.
公开(公告)号:CA2152822A1
公开(公告)日:1995-05-11
申请号:CA2152822
申请日:1994-10-20
Applicant: ABBOTT LAB
Inventor: BAKER WILLIAM R , ROCKWAY TODD W , DONNER B GREGORY , SHEN WANG , ROSENBERG SAUL H , FAKHOURY STEPHEN A , O'CONNOR STEPHEN J , STOUT DAVID M , FUNG ANTHONY K L , GARVEY DAVID S , PRASAD RAJNANDAN , SULLIVAN GERARD M
IPC: C12N9/99 , A61K31/195 , A61K31/215 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/36 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/41 , A61K31/42 , A61K31/421 , A61K31/4245 , A61K31/44 , A61K31/4409 , A61K31/4418 , A61P3/06 , A61P7/00 , A61P9/10 , A61P31/04 , A61P43/00 , C07C69/52 , C07C69/74 , C07C231/02 , C07C233/19 , C07C233/58 , C07C233/59 , C07C233/60 , C07C233/61 , C07C233/62 , C07C233/63 , C07C235/36 , C07C235/40 , C07C237/24 , C07C245/14 , C07C251/42 , C07C259/08 , C07C275/26 , C07C311/51 , C07C323/40 , C07C323/46 , C07C327/20 , C07C327/36 , C07C327/38 , C07D207/325 , C07D213/40 , C07D257/04 , C07D257/06 , C07D263/24 , C07D271/06 , C07D271/10 , C07D277/20 , C07D277/34 , C07D285/16 , C07D285/18 , C07D307/42 , C07D307/52 , C07D309/32 , C07D317/60 , C07D319/06 , C07D333/08 , C07D333/58 , C07C235/82 , A61K31/33 , C07D207/337 , C07D249/02 , C07D285/06 , C07D307/54 , C07D333/24
Abstract: The present invention provides a compound of formula (I) processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and a method of treating disorders resulting from an excess of cholesterol or cancer or a fungal infection.
-
公开(公告)号:BR0110101A
公开(公告)日:2005-06-07
申请号:BR0110101
申请日:2001-09-20
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI DAVID J , BAUMEISTER STEVEN A , DICKMAN DANIEL A , DING HONG , DINGES JURGEN , FESIK STEPHEN W , HAJDUK PHILIP J , KUNZER AARON R , NETTESHEIM DAVID G , PETROS ANDREW M , ROSENBERG SAUL H , SHEN WANG , THOMAS SHEELA A , WENDT MICHAEL D
IPC: A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107 , C07C311/00
-
公开(公告)号:DE69615674T2
公开(公告)日:2002-07-11
申请号:DE69615674
申请日:1996-04-18
Applicant: ABBOTT LAB
Inventor: ARENDSEN L , BAKER R , FAKHOURY A , FUNG L , GARVEY S , MCCLELLAN J , O'CONNOR J , PRASAD N , ROCKWAY W , ROSENBERG H , STEIN H , SHEN WANG , STOUT M , SULLIVAN M , AUGERI J
IPC: A61K31/195 , A61K31/215 , A61K31/38 , A61K31/381 , A61K31/41 , A61K31/4245 , A61K31/433 , A61P3/06 , A61P9/00 , A61P9/08 , A61P31/04 , A61P35/00 , A61P43/00 , C07C233/58 , C07C233/59 , C07C233/60 , C07C235/40 , C07C235/82 , C07D271/06 , C07D271/10 , C07D285/10 , C07D333/20 , A61K31/19 , A61K31/16
Abstract: The present invention provides a compound of formula (II) or a pharmaceutically acceptable salt thereof, which is useful for inhibiting protein farnesyltransferase and the farnesylation of the oncogene protein Ras, processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and to methods of using such compounds.
-
公开(公告)号:PE20020504A1
公开(公告)日:2002-06-20
申请号:PE2001000940
申请日:2001-09-19
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , WANG XILU , BAUMEISTER STEVEN A , DING HONG , FESIK STEPHEN W , KUNZER AARON R , PETROS ANDREW M , WENDT MICHAEL D , THOMAS SHEELA A , SHEN WANG , ROSEMBERG SAUL H , NETTERSHEIM DAVID G , HAJDUK PHILIP J , DINGES JURGEN , DICKMAN DANIEL A , AUGERI DAVID J , BRUNCKO MILAN
IPC: C07C311/00 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/12 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/96 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/61 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D235/08 , C07D235/26 , C07D241/16 , C07D249/04 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D401/06 , C07D401/12 , C07D405/04 , C07D417/12 , C07D451/02
Abstract: SE REFIERE A N-ACILSULFONAMIDAS DE FORMULA I DONDE A ES FENILO, ANILLO CARBOCICLICO AROMATICO DE 5-6 MIEMBROS; R1 ES ALQUILO, HALOALQUILO, NITRO, NR5R6; R2 Y R3 SON H, ALQUENILO, ALCOXI, ALQUILO, ALQUILSULFANILO, ALQUINILO, ARILO, ARILALCOXI, ENTRE OTROS; R4 ES ARILO, ARILALQUENILO, ARILALCOXI, ARILOXI, ARILOXIALCOXI, ENTRE OTROS; R5 Y R6 SON HIDROGENO, ALQUENILO, ALCOXIALQUILO, ENTRE OTROS; R5 Y R6 JUNTO A N FORMAN UN IMIDAZOLILO, MORFOLINILO, PIPERAZINILO, PIPERIDINILO, ENTRE OTROS; R15 ES H, ALQUILO, HALO. SON COMPUESTOS PREFERIDOS 4-((2,2-DIMETILCICLOPENTIL)AMINO)-N-((4´FLUORO(1,1'-BIFENIL)-4-IL)CARBONIL)-3-NITROBENCENSULFONAMIDA, 4-(CICLOHEXILAMINO)-N-((4´FLUORO(1,1'-BIFENIL)-4-IL)CARBONIL)-3-NITROBENCENSULFONAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. LOS COMPUESTOS MENCIONADOS SON PROMOTORES DE LA APOPTOSIS Y SON UTILES PARA EL TRATAMIENTO DEL CANCER
-
公开(公告)号:AT206390T
公开(公告)日:2001-10-15
申请号:AT96912978
申请日:1996-04-18
Applicant: ABBOTT LAB
Inventor: ARENDSEN DAVID L , BAKER WILLIAM R , FAKHOURY STEPHEN A , FUNG K L ANTHONY , GARVEY DAVID S , MCCLELLAN WILLIAM J , O'CONNOR STEPHEN J , PRASAD RAJNANDAN N , ROCKWAY TODD W , ROSENBERG SAUL H , STEIN HERMAN H , SHEN WANG , STOUT DAVID M , SULLIVAN GERARD M , AUGERI DAVID J
IPC: A61K31/195 , A61K31/215 , A61K31/38 , A61K31/381 , A61K31/41 , A61K31/4245 , A61K31/433 , A61P3/06 , A61P9/00 , A61P9/08 , A61P31/04 , A61P35/00 , A61P43/00 , C07C233/58 , C07C233/59 , C07C233/60 , C07C235/40 , C07C235/82 , C07D271/06 , C07D271/10 , C07D285/10 , C07D333/20 , A61K31/19
Abstract: The present invention provides a compound of formula (II) or a pharmaceutically acceptable salt thereof, which is useful for inhibiting protein farnesyltransferase and the farnesylation of the oncogene protein Ras, processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and to methods of using such compounds.
-
公开(公告)号:DK0677039T3
公开(公告)日:1999-09-27
申请号:DK94931987
申请日:1994-10-20
Applicant: ABBOTT LAB
Inventor: BAKER WILLIAM R , DONNER B GREGORY , FAKHOURY STEPHEN A , FUNG ANTHONY K L , GARVEY DAVID S , O'CONNOR STEPHEN J , PRASAD RAJNANDAN , ROCKWAY TODD W , ROSENBERG SAUL H , SHEN WANG , STOUT DAVID M , SULLIVAN GERARD M
IPC: C12N9/99 , A61K31/195 , A61K31/215 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/36 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/41 , A61K31/42 , A61K31/421 , A61K31/4245 , A61K31/44 , A61K31/4409 , A61K31/4418 , A61P3/06 , A61P7/00 , A61P9/10 , A61P31/04 , A61P43/00 , C07C69/52 , C07C69/74 , C07C231/02 , C07C233/19 , C07C233/58 , C07C233/59 , C07C233/60 , C07C233/61 , C07C233/62 , C07C233/63 , C07C235/36 , C07C235/40 , C07C237/24 , C07C245/14 , C07C251/42 , C07C259/08 , C07C275/26 , C07C311/51 , C07C323/40 , C07C323/46 , C07C327/20 , C07C327/36 , C07C327/38 , C07D207/325 , C07D213/40 , C07D257/04 , C07D257/06 , C07D263/24 , C07D271/06 , C07D271/10 , C07D277/20 , C07D277/34 , C07D285/16 , C07D285/18 , C07D307/42 , C07D307/52 , C07D309/32 , C07D317/60 , C07D319/06 , C07D333/08 , C07D333/58 , A61K31/16
-
公开(公告)号:BRPI0110101B1
公开(公告)日:2016-08-23
申请号:BR0110101
申请日:2001-09-20
Applicant: ABBOTT LAB , ABBVIE INC
Inventor: KUNZER AARON R , PETROS ANDREW M , DICKMAN DANIEL A , NETTESHEIM DAVID G , AUGERI DAVID J , DING HONG , DINGES JURGEN , WENDT MICHAEL D , BRUNCKO MILAN , HAJDUK PHILIP J , ROSENBERG SAUL H , THOMAS SHEELA A , FESIK STEPHEN W , BAUMEISTER STEVEN A , OOST THORSTEN , SHEN WANG , MCCLELLAN WILLIAM , WANG XILU
IPC: C07C311/00 , A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107
Abstract: "n-acil-sulfonamidas promotoras de apoptose". descreve-se n-benzoil-aril-sulfonamidas que têm a fórmula (i), são inibidores de bcl-x1, e úteis para promover apoptose. descreve-se também composições e métodos inibidores de bcl-xl para promover apoptose em um mamífero.
-
公开(公告)号:CA2612260C
公开(公告)日:2013-10-29
申请号:CA2612260
申请日:2006-07-07
Applicant: ABBOTT LAB
Inventor: WENDT MICHAEL D , SHEN WANG , DICKMAN DANIEL A , DING HONG , THOMAS SHEELA A , AUGERI DAVID , ELMORE STEVEN W
IPC: C07C63/64 , A61K31/192 , A61P35/00
Abstract: Compounds which inhibit the activity of anti-apoptotic Mcl-I protein, compositions containing the compounds and methods of treating diseases during which are expressed the Mcl- 1 protein are disclosed.
-
公开(公告)号:MX2007016070A
公开(公告)日:2008-03-10
申请号:MX2007016070
申请日:2006-07-07
Applicant: ABBOTT LAB
Inventor: WENDT MICHAEL D , DICKMAN DANIEL A , DING HONG , ELMORE STEVEN W , SHEN WANG , THOMAS SHEELA A , AUGERI DAVID
IPC: A61K31/192 , A61P35/00 , C07C15/12
Abstract: Se describen compuestos que inhiben la actividad de la proteina Mcl-1 anti-apoptotica, las composiciones conteniendo los compuestos y metodos para el tratamiento de enfermedades durante las cuales se expresa la proteina Mcl-1.
-
-
-
-
-
-
-
-
-